Santaris Pharma A/S

Santaris Pharma A/S is a company in Horsholm, Denmark that has taken part in 3 EU-funded projects since 2012, receiving €1.5M in EU funding.

EU funding received€1.5M
EU projects3
As coordinator0
Running now0
First EU project2012
Latest project2013
CountryDenmark
EU registration (PIC)993182031
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Santaris Pharma A/S's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€1.5M · 3 projects

Projects

3 EU-funded projects, newest first. Each links to the official record.

  • Athero-B-CellPartner

    Targeting and exploiting B cell functions for treatment in cardiovascular disease

    FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

    €1.0Mtheir share
  • Athero-FluxPartner

    Targeting novel lipid pathways for treatment of cardiovascular disease

    FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

    €517ktheir share
  • CARDIOMIRPartner

    Development of microRNA Medicines for Cardiac Metabolic Diseases; A Targeted European Exchange Programme

    FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • RNA
  • arteriosclerosis
  • cardiovascular diseases
  • data science
  • drug discovery
  • genetic engineering
  • inflammatory diseases
  • lipids
  • mortality
  • nucleotides
  • proteins
  • vaccines

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime